Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The regulator of chromosome condensation 2 pseudogene (LOC100129949, ENSG00000270818) is a non-protein-coding genomic segment that resembles the functional RCC2 gene. Pseudogenes like this one arise from duplications or retrotranspositions of ancestral genes and typically lose protein-coding potential due to accumulated mutations[1][3]. Some pseudogenes can be transcribed, and there is increasing evidence that pseudogene RNAs may play regulatory roles, such as acting as microRNA decoys or producing small RNAs that influence the expression of functional genes[1][4]. However, this pseudogene is not known to bind drugs or to serve as a therapeutic target, receptor, enzyme, or biomarker in clinical practice. No mechanistic or safety information specific to this pseudogene is established. While pseudogenes may be relevant in the context of genomic regulation and disease—especially cancer—there is no direct evidence tying ENSG00000270818 (LOC100129949) to a specific therapeutic or disease process[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of chromosome condensation 2 pseudogene.